Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis

Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis

(2015) Britta Galling et al.   Expert Opinion On Drug Safety

Duloxetine-bupropion combination for treatment-resistant atypical depression: A double-blind, randomized, placebo-controlled trial

(2014) Michele Fornaro et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment

(2014) Susan Ball et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidepressant treatment response is modulated by genetic and environmental factors and their interactions

(2014) Dávid Kovacs et al.   Annals of General Psychiatry

Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression

(2013) Chia-Ming Chang et al.   CNS DRUGS

Combination antidepressant therapy for major depressive disorder: Speed and probability of remission

(2013) Jonathan W. Stewart et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Efficacy and safety of add on low-dose mirtazapine in depression

(2012) DineshK Badyal et al.   INDIAN JOURNAL OF PHARMACOLOGY

Antidepressant combination for major depression in incomplete responders—a systematic review

(2012) Fábio Lopes Rocha et al.   JOURNAL OF AFFECTIVE DISORDERS

Combination of Antidepressants in the Treatment of Major Depressive Disorder

(2012) Fábio Lopes Rocha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge

(2012) Liesbeth Decoutere et al.   International Journal of Clinical Pharmacy

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

(2011) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Bupropion as an Augmenting Agent in Patients of Depression with Partial Response

(2011) Gaurav Gulrez et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Serotonin toxicity: a short review of the literature and two case reports involving Citalopram

(2011) G. Talarico et al.   NEUROLOGICAL SCIENCES

If at First You Donʼt Succeed

(2010) K. Ryan Connolly et al.   DRUGS

Clinically Relevant Pharmacokinetic Interaction Between Venlafaxine and Bupropion

(2010) Georgios Paslakis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Antidepressants: Clinically Relevant Drug Interactions to Be Considered

(2010) Rene Schellander et al.   PHARMACOLOGY

Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study

(2009) Pierre Blier et al.   AMERICAN JOURNAL OF PSYCHIATRY

Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression

(2009) Norio Watanabe et al.   CNS DRUGS

Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation

(2009) Pierre Blier et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression

(2009) Sandra Vezmar et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder

(2008) Hikaru Hori et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

(2007) Charles B. Nemeroff et al.   BIOLOGICAL PSYCHIATRY